Aug. 17, 2009 (Business Wire) -- AmerisourceBergen Corporation (NYSE: ABC) today announced organizational changes, effective September 1, 2009, to better position the Company to continue to achieve its long-term financial goals.
Steven H. Collis will become Executive Vice President AmerisourceBergen and President of AmerisourceBergen Drug Corporation (ABDC), the Company’s largest subsidiary. Collis was previously Executive Vice President and President of AmerisourceBergen Specialty Group (ABSG). He led ABSG from a start-up company in 1994 to the approximately $15 billion subsidiary it is today. In his new role, he will lead the ABDC organization. He continues to report directly to R. David Yost, President and Chief Executive Officer of AmerisourceBergen Corporation.
“ABDC has been very successful since we began running it with Executive Vice President and Chief Financial Officer Mike DiCandilo leading operations and me leading sales and marketing,” said Yost. “To drive future performance, we are consolidating those functions under one leader, and I am very pleased that Steve Collis will be applying his substantial management talent to lead ABDC. At the same time, Mike DiCandilo will continue his corporate role with ABDC in finance, supply chain management and our very important Business Transformation ERP project. The result will be an even more focused organization.”
Michael D. DiCandilo, continues as Executive Vice President and Chief Financial Officer of AmerisourceBergen, with on-going responsibility for all corporate financial operations, supply chain management, AmerisourceBergen Packaging Group, and information technology, including the Company’s Business Transformation ERP project. He continues to report directly to Yost.
Michael A. Mullen will lead ABSG as Chief Operating Officer, AmerisourceBergen Specialty Group, also reporting directly to Yost. Prior to his new assignment, Mullen, who has been with ABSG for six years, was President of Distribution Services at ABSG, previously served as the chief financial officer for the subsidiary, and has been a key force behind the long-running success of ABSG.
About AmerisourceBergen
AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With more than $70 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 10,000 people. AmerisourceBergen is ranked #26 on the Fortune 500 list.
